이상반응 보고

VAERS ID	2001795
성별	여성
나이	79세
주 코드	TX
제약회사	MODERNA
로트 번호	046A21A
예방접종 횟수	2
접종일	2021-03-29
발병일	2021-12-27
상태	입원 사망

증상

• 호흡곤란(Dyspnoea)
• 상태가 악화됨(Condition aggravated)
• 기침(Cough)
• 코 막힘(Nasal congestion)
• SARS-CoV-2 테스트 양성(SARS-CoV-2 test positive)
• 코로나 바이러스 감염증 -19 : 코로나 19(COVID-19)
• 코로나19 폐렴(COVID-19 pneumonia)
• 죽음(Death)
• 전반적인 신체 건강 악화(General physical health deterioration)
• 급성 호흡 부전(Acute respiratory failure)
• 간질성 폐질환(Interstitial lung disease)
• 심인성 쇼크(Cardiogenic shock)

이환 중 질병

지병

Idiopathic pulmonary fibrosis, Hypertension, Hyperlipidemia, metabolic alkalosis, interstitial lung disease, diastolic congestive heart failure, chronic respiratory failure on supplemental oxygen at home, benign paroxysmal positional vertigo, anxiety, depression, cough variant asthma, colon polyp, GERD, irritable bowel syndrome, obesity, shingles, skin cancer.

기타 의료

Acetaminophen 500 mg Q6H PRN, Apixaban 5 mg BID, Bupropion, 75 mg QD, Digoxin 0.125 mg QD, Furosemide 40mg QD, Gabapentin 900 mg TID, Metoprolol 25 mg BID, Omeprazole 40 mg QD, Potassium Chloride 20 mEq QD, Prednisone 40 mg QD, Saccharomyc

이전 예방접종

알레르기

Penicillins, Influenza Vaccine, Nystatin, Statins, Toradol

임상 검사

COVID-19 positive on 12/27/2021 using the BioFire FilmArray.

증상 상세

Moderna COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death.
Patient received Moderna Vaccines on 2/27/2021 and 3/29/2021.
PMHx HTN, CHF, COPD on O2 at home and BPPV w/prior recent admission for cardiogenic shock.
Presented to ED 12/27/2021 with worsening shortness of breath, dry cough, and nasal congestion that began on 12/23/2021 w/O2 sats 77% on room air, tx'd w/HFNC, methylprednisolone and remdesivir.
Cont'd to decline, requiring maximum support on HFNC and NRB oxygen.
Code status on admission was "Do Not Intubate".
Expired 1/1/2022 due to acute on chronic respiratory failure from Covid-19 PNA and interstitial lung disease.